This VESPA evening seminar does not specifically pertain to patent litigation. Still, I do believe that it addresses a hot topic that will also have an impact on the contentious side of IP: The use of AI in our daily work as patent attorneys / lawyers in IP. → Read more ...
*** BREAKING *** ‘Silent Argument’ Option at the FPC, with Fee Reduction
Phantastic news from a usually well-informed source: In a pioneering move to offer more flexibility in court proceedings, the Swiss FPC is about to implement a ‘Silent Argument’ option, complemented by a fee reduction incentive. → Read more ...
Back to basics: What is an invention, for heaven’s sake?
Case No. B-1711/2023 (FAC) | Hearing of 26 March 2024 | ‘Technicity’
Swiss patent applications are not currently examined on the merits. → Read more ...
UPC: Case summaries and PPT presentations at hearings
It’s interesting these days to follow how the UPC approaches certain procedural things. According to a recent order of the Central Division (Section Munich) a party was allowed to use slides as demonstratives at a main hearing. → Read more ...
The FPC’s Annual Report 2023
The official Annual Report 2023 of the FPC has been published earlier today (12 March 2024). It comes along with an Executive Summary as follows:
In the reporting year, the total number of incoming cases increased to 31 (previous year 24). |
Final call for the annual FPC case-law seminar on Thu, Feb 8 in Lausanne
Hurry up, it is still possible to sign up for the 11th edition of the joint AROPI – VESPA seminar
La jurisprudence suisse en matière de brevets en 2023
on at the Alpha-Palmiers hotel, rue du Petit-Chêne 34, 1003 Lausanne. → Read more ...
Novartis’ pre-filled syringe patents for Lucentis™ under attack 💉
Case No. O2022_004 | Hearing of 21 November 2023 | ‘Ranibizumab PFS’
This is litigation between Bioeq and Novartis about (in)validity of five patents relating to Novartis’ Lucentis® (ranibizumab) in a pre-filled syringe (PFS; see Compendium), for direct application into the eye of a patient. → Read more ...
Deferasirox not only chelates iron, but also the scope of numerical ranges
Case No. 4A_273/2023 (SC) | Judgment of 25 September 2023
on appeal against
Case No. O2021_004/5 (FPC) | Judgment of 20 April 2023 | ‘Deferasirox’
This case is about deferasirox, an iron chelating agent. → Read more ...
Suspensive effect of post-grant appeals: Don’t enact it like this, please … 🙏
I have reported several times about the substantial revision of the Swiss Patent Act that is currently in the making; see e.g. → Read more ...
You recognize a tourbillon when you see it? Think twice.
Case Nos. O2021_008, O2021_016 | Hearing of 31 May 2023 | ‘Escape II’
This litigation between Greubel Forsey and Purnell is about a very special kind of wrist watch. → Read more ...
🇨🇭 Patent Litigation // 🔥 Fireside Chat #26 // 27 September 2023
Just in case you missed the LinkedIn Live session of Wed, 27 September 2023, here’s a recording:
This episode covers the following:
👉 H. → Read more ...